SCHEMBL27648293

SCHEMBL27648293

CC(C)(C)OC(=O)N1CCN(C2CCN(CCc3ccccc3)CC2)CC1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.56
HRH3 Q9Y5N1 1/20 0.51
STS P08842 1/20 0.49
ACHE P22303 2/20 0.48
SIGMAR1 Q99720 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GPR119 Q8TDV5 2/20 0.48
HTR2A P28223 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
KCNH2 Q12809 1/20 0.47
JAK2 O60674 1/20 0.47
JAK1 P23458 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3570582 0.88 ACHE (0.61) MAPTSTSACHEKDM4EALDH1A1
SCHEMBL3712707 0.88 MEN1 (0.59) STSSIGMAR1MEN1KMT2AKCNH2
SCHEMBL13443092 0.84 ACHE (0.54) MAPTSTSACHEKDM4EALDH1A1
SCHEMBL3779080 0.84 CHRM4 (0.56) MAPTSTSACHEKDM4EALDH1A1
SCHEMBL7986044 0.83 SIGMAR1 (0.55) ACHESIGMAR1MEN1KMT2AKCNH2
SCHEMBL27430030 0.83 MAPT (0.64) MAPTHRH3ACHESIGMAR1KDM4E
SCHEMBL7362773 0.83 CHRM4 (0.59) MAPTACHEKDM4EALDH1A1GPR119
Hydrochloric Acid SCHEMBL3966170 0.83 CHRM4 (0.55) MAPTSTSACHEKDM4EALDH1A1
SCHEMBL119649 0.83 SMN1; SMN2 (0.58) HRH3STSSIGMAR1KDM4EGPR119
SCHEMBL310136 0.83 SMN1; SMN2 (0.58) HRH3STSSIGMAR1KDM4EGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1738805-A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache BOEHRINGER INGELHEIM INT (DE) 2006-02-22 CN disclosed